Dialysis Market Analysis 2026

Market Dynamics of the Dialysis Market

Key Drivers

• The rise in the frequency of chronic kidney disease and renal failure driver the market growth for Dialysis 

Diabetes and hypertension are the primary causes of chronic kidney disease (CKD), a non-communicable illness. Patients with chronic kidney disease (CKD) are mostly at risk for early morbidity and mortality due to cardiovascular disease. When one or both kidneys fail to function properly, a patient with end-stage renal disease (ESRD) needs long-term renal infusion therapy or a kidney transplant. Consequently, an increasing number of ESRD and chronic kidney disease cases are driving up the global economic burden of healthcare and dialysis. For Instance, according to the Centre for Disease Control and Prevention, In the US, kidney illnesses are one of the main causes of death. It is estimated that 37 million persons in the US have CKD, most of whom are misdiagnosed. Of those without dialysis who have substantially diminished kidney function, 40% do not know they have chronic kidney disease (CKD). Thirty-six persons a day start dialysis for renal failure.

Hence, Dialysis is one option available when CKD, and the market for it is growing. The most severe stage of chronic kidney disease (CKD) is called Stage 5. Patients with Stage 5 CKD are typically seen to be good candidates for kidney transplantation or to begin dialysis treatment. End Stage Renal Disease is the term used when dialysis or transplantation is deemed required (ESRD). Two main forms of dialysis therapy are hemodialysis and peritoneal dialysis. Because diabetes and hypertension are on the rise, the population is experiencing an increased risk of renal disease and renal failure. Diabetic nephropathy, a common consequence of both type 1 and type 2 diabetes, is brought on by injury to the kidney's blood vessel clusters, which support the body's elimination of waste and eventually result in renal dysfunction. The market is expanding as a result of various factors, including aging, obesity, and unhealthy lifestyles that raise the incidence of diabetes causing chronic kidney disease and renal failure. Thus, Such a strong and increasing rate of cases increases the demand for the dialysis market and growth in the upcoming years.

• The increase in the number of Dialysis Centers and improvement in the facilities is driving the growth of the Market.

Research found that about 25% of dialysis patients resided more than 100 kilometers distant from the facility, while nearly 60% of patients had to drive more than 50 kilometers to obtain HD. In addition, there aren't many pediatric dialysis providers and women are underrepresented in the field.  (Source: https://www.expresshealthcare.in/news/increased-government-initiatives-and-partnerships-needed-for-dialysis-patients/436729/)Thus, there is a great chance to rethink dialysis care and increase the use of cutting-edge facilities while lowering patient out-of-pocket costs, especially for those from weaker demographics. As there are increasing number of patients who are subject to dialysis treatment, the healthcare facilities in low and middle-income countries are growing. As there is more demand for dialysis private hospitals and the treatment of kidney diseases are on the rise. There are various government initiatives for the same. For Instance, Ayushman Bharat an initiative by the Indian Government, launched on April 6, 2022, the updated Health Benefits Package 2.2 includes 365 new treatments and increases dialysis treatment relief from Rs 1,500 to Rs 1,800 to account for long-term inflationary trends. The idea is to have a dialysis facility in each of the 750 districts. Many of the more than 24,000 facilities accredited under the program are in the private sector, providing users with a variety of treatment options.(Source:https://health.economictimes.indiatimes.com/news/industry/ayushman-bharat-brings-relief-to-dialysis-patients/93404311#:~:text=In%20the%20revised%20Health%20Benefit,least%20one%20dialysis%20centre%20each.) Hence, the need for hemodialysis centers has grown among patients and there has been a substantial increase in the Dialysis centers which drives the market growth.

 Key Restraints of Dialysis Market

• High cost of Dialysis treatment and increase in risk hampers the market growth.

Sepsis, or blood poisoning, is more common in patients undergoing hemodialysis. This is the point of entry for germs into the body, which can then travel throughout the blood and cause multiple organ failure. There is an increase in the risk after starting or during dialysis. For Instance, 68 individuals in the Harvard study were 85 years of age or older, 89 needed help with everyday tasks, and 267 had four or more serious medical issues. Following the initiation of dialysis, approximately 23% of patients passed away within a month, roughly 45% within six months, and approximately 55% within a year.
(Source:https://www.medtechdive.com/news/more-patients-die-after-starting-dialysis-than-registry-suggests-harvard-s/553221/#:~:text=In%20the%20Harvard%20study%2C%2068,55%25%20died%20within%20the%20year.) Dialysis is a necessary treatment that involves a team of medical professionals and is scheduled multiple times per week. The cost of dialysis is frequently combined with additional costs associated with maintaining your illness. There are a few reasons why dialysis can be costly. First off, dialysis treatment involves complex machinery and technology that can only be operated by medical professionals with certain training. The total cost is also influenced by the cost of labor, which includes highly skilled medical personnel. Additionally, dialysis treatment is frequently needed regularly—sometimes even several times a week—which can quickly mount up in expenses. The cost of supplies, drugs, and equipment upkeep for the dialysis machine also adds to the total cost. The insurance plan and healthcare systems are important factors in deciding the out-of-pocket costs. Due to the above reasons, the cost of dialysis is high, and low or middle-income people are hesitant to get the treatment and the risk of getting other diseases or death in dialysis hampers the market growth. 

• Risks and Complications Associated with this procedures to Slow Down Market Growth

Dialysis, though a life-extending therapy in patients with end-stage renal disease (ESRD), is related to a range of risks and complications that function as major inhibitors on its greater diffusion and expansion in the market. The most frequent complication is vascular access complication, such as infections, clotting, and vascular narrowing. Not only does it raise the hospitalization rate, but also the overall expense and complexity of treatment. The other key concern is the great potential for infection, especially with peritoneal dialysis, where the peritoneal space is continually exposed. Infections in this case can lead to severe diseases such as peritonitis, which often involves hospitalization or a transition to hemodialysis, thus deterring patient preference for home therapies.

Dialysis patients are similarly at higher risk for cardiovascular complications, including arrhythmias and hypotension during or following treatment. Such occurrences can prove fatal and drastically reduce the perceived safety of the procedure.
Also, dialysis fatigue, nausea, and dietary limitations impact patients' quality of life, frequently causing treatment non-adherence. These issues add to low patient retention and discourage prospective new patients from pursuing dialysis unless inevitable.

The mental impact depression, worry, and social isolation also adds to the resistance to initiate or continue dialysis therapy.
These medical and emotional challenges, along with the need for ongoing monitoring and intervention, act as barriers to market expansion. As a result, the dialysis industry faces hurdles in both patient acceptance and the scaling of treatment infrastructure.

What was the Impact of COVID-19 on the Dialysis Market?

Coronavirus disease, the greatest global epidemic in a century, has disproportionately affected those on maintenance dialysis and medical professionals. The population receiving dialysis is severely impacted by the COVID-19 epidemic. Dialysis patients are more likely to contract SARS-CoV-2, which increases their risk of infection and death. Serious COVID-19 sickness is more likely to affect older adults, those with kidney disease, and those with other serious chronic medical illnesses. Dialysis patients may have weakened immune systems, which makes infection prevention more difficult. It is crucial to remember that renal patients must continue with their regularly scheduled dialysis sessions and follow their healthcare team's suggested safety measures. For Instance, “Dialysis equipment is now more important than ever. The market will undoubtedly grow as more COVID-19 patients are expected to need dialysis treatment. The pandemic has increased the risk of supply chain flaws and equipment scarcity. In the upcoming weeks, more hospital resources are probably going to be fully utilized. But the preservation of essential life-saving machinery, like dialysis machines”. Said Aliyah Farouk, MSc, Medical Devices Analyst at Global Data (Source:https://www.globaldata.com/media/medical-devices/renal-dialysis-equipment-market-will-be-fuelled-by-covid-19-related-equipment-shortages/)Hence, the risk of having kidney failure for patients with COVID-19 so there as a positive impact on the Dialysis Market.

Opportunities of the dialysis

• Technological advancements in dialysis machines to offer market

Dialysis technology improvements hold big promise for augmenting patient care, optimizing treatment efficacy, and speeding market development. Contemporary dialysis equipment is more and more being equipped with smart technologies including automatic fluid management, real-time monitoring, and personalized treatment adjustment. These smart features decrease complication risks, maximize efficiency, and provide greater dialysis session precision, ultimately raising the bar in terms of patient safety and patient comfort.
Morden dialysis technology are of various types of sysytem. Implantable artificial kidney is newly emerging technology.
For instance, An artificial kidney is a medical device that performs the same function as a kidney. Portable dialysis can be considered as an artificial kidney, Dr. Roy said. "The Kidney Project's artificial kidney is an implantable biomedical device that will operate like a natural kidney and administer 24/7 treatment. Although the team's ultimate long-term goal is to replace all of the kidney's functions, the initial models operate like kidneys in stage three or four kidney disease.".
(Source- https://www.kidney.org/news-stories/)
Another significant breakthrough is the evolution of wearable and portable dialysis machines. The small devices enable patients to receive treatment away from conventional clinical facilities, providing them with increased flexibility, mobility, and autonomy. This trend towards home-based and wearable dialysis technologies is anticipated to enhance access to treatment, particularly for remote populations or patients with mobility impairments.
Telemedicine and remote monitoring integration also complements the adoption of home dialysis since it enables healthcare providers to monitor patients' vitals and machine operation in real-time. This not only guarantees continuity of care but also decreases the load on dialysis units and hospitals.Additionally, incorporation of artificial intelligence (AI) and data analytics in dialysis machines allows predictive maintenance, individualized treatment protocols, and timely identification of likely complications, thus resulting in improved clinical outcomes.
Thus, As global healthcare systems emphasize cost-saving and patient-oriented care, these technology advancements will fuel rapid growth in the dialysis market. Next-generation dialysis machines are revolutionizing treatment delivery and opening opportunities for patients and providers alike through enhanced convenience, safety, and accessibility.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Dialysis Market is witnessing significant growth in the near future.

In 2023, the Equipment segment accounted for noticeable share of global Dialysis Market and is projected to experience significant growth in the near future.

The Dialyzers segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Baxter International , B. Braun Medical Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions